
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Nasdaq · Laboratory Analytical Instruments
Company Overview
A concise company profile alongside the latest public filing activity.
Pacific Biosciences of California develops and manufactures DNA sequencing systems based on its single-molecule, real-time (SMRT) sequencing technology, selling instruments, consumables, and related software to research institutions, clinical labs, and biopharmaceutical companies for genomic analysis.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Gibson James R IISee Remarks | Sell | $2.06M | 661,815at $3.11 | Oct 6, 2026 |
| Van Oene MarkSee Remarks | Sell | $30K | 26,911at $1.13 | Aug 17, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable PACB activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.